9-氨甲基-9,10-二氢蒽
 | |
| 识别信息 | |
|---|---|
| |
| CAS号 | 22136-76-1  N |
| PubChem CID |
|
| ChemSpider |
|
| UNII |
|
| ChEMBL |
|
| CompTox Dashboard（英语：CompTox Chemicals Dashboard） (EPA) |
|
| 化学信息 | |
| 化学式 | C15H15N |
| 摩尔质量 | 209.29 g·mol−1 |
| 3D模型（JSmol（英语：JSmol）） |
|
| |
| |
9-氨甲基-9,10-二氢蒽（英语：9-Aminomethyl-9,10-dihydroanthracene），简称AMDA，是一种有机化合物，可作为5-HT2A受体的有效选择性拮抗剂。[1]它已被用于帮助研究5-HT2A蛋白的形状，[2]并开发出一大类具有更高效力和选择性的相关衍生物。[3][4][5][6][7]
参考资料
- ^ Westkaemper RB, Runyon SP, Bondarev ML, Savage JE, Roth BL, Glennon RA. 9-(Aminomethyl)-9,10-dihydroanthracene is a novel and unlikely 5-HT2A receptor antagonist. European Journal of Pharmacology. September 1999, 380 (1): R5–7. PMID 10513561. doi:10.1016/S0014-2999(99)00525-7.
- ^ Runyon SP, Peddi S, Savage JE, Roth BL, Glennon RA, Westkaemper RB. Geometry-affinity relationships of the selective serotonin receptor ligand 9-(aminomethyl)-9,10-dihydroanthracene. Journal of Medicinal Chemistry. April 2002, 45 (8): 1656–64. PMID 11931619. doi:10.1021/jm010354g.
- ^ Peddi S, Roth BL, Glennon RA, Westkaemper RB. Spiro[9,10-dihydroanthracene]-9,3'-pyrrolidine-a structurally unique tetracyclic 5-HT2A receptor antagonist. European Journal of Pharmacology. December 2003, 482 (1–3): 335–7. PMID 14660041. doi:10.1016/j.ejphar.2003.09.059.
- ^ Peddi S, Roth BL, Glennon RA, Westkaemper RB. Structural determinants for high 5-HT(2A) receptor affinity of spiro[9,10-dihydroanthracene]-9,3(')-pyrrolidine (SpAMDA). Bioorganic & Medicinal Chemistry Letters. May 2004, 14 (9): 2279–83. PMID 15081025. doi:10.1016/j.bmcl.2004.02.014.
- ^ Dewkar GK, Peddi S, Mosier PD, Roth BL, Westkaemper RB. Methoxy-substituted 9-aminomethyl-9,10-dihydroanthracene (AMDA) derivatives exhibit differential binding affinities at the 5-HT(2A) receptor. Bioorganic & Medicinal Chemistry Letters. October 2008, 18 (19): 5268–71. PMC 3082371
. PMID 18774714. doi:10.1016/j.bmcl.2008.08.059. - ^ Runyon SP, Mosier PD, Roth BL, Glennon RA, Westkaemper RB. Potential modes of interaction of 9-aminomethyl-9,10-dihydroanthracene (AMDA) derivatives with the 5-HT2A receptor: a ligand structure-affinity relationship, receptor mutagenesis and receptor modeling investigation. Journal of Medicinal Chemistry. November 2008, 51 (21): 6808–28. PMC 3088499 . PMID 18847250. doi:10.1021/jm800771x.
- ^ Shah JR, Mosier PD, Peddi S, Roth BL, Westkaemper RB. 9-Aminomethyl-9,10-dihydroanthracene (AMDA) analogs as structural probes for steric tolerance in 5-HT2A and H1 receptor binding sites. Bioorganic & Medicinal Chemistry Letters. February 2010, 20 (3): 935–8. PMC 3252747 . PMID 20045641. doi:10.1016/j.bmcl.2009.12.064.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 | 这是一篇作用於神经系统的藥品小作品。您可以通过编辑或修订扩充其内容。
|
